Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Design Therapeutics (DSGN) Return on Sales (2020)

Design Therapeutics' Return on Sales history spans 1 years, with the latest figure at 1.17% for Q4 2020.

  • On a quarterly basis, Return on Sales changed N/A to 1.17% in Q4 2020 year-over-year; TTM through Dec 2020 was 0.37%, a N/A change, with the full-year FY2020 number at 0.37%, changed N/A from a year prior.
  • Return on Sales hit 1.17% in Q4 2020 for Design Therapeutics, up from 1.19% in the prior quarter.
  • Over the last five years, Return on Sales for DSGN hit a ceiling of 0.04% in Q1 2020 and a floor of 1.19% in Q3 2020.